If you’re providing body contouring services to patients, chances are you’re doing it differently than you were a decade ago, according to a presentatin by Dr. Mathew Avram from the 2018 AAD Summer Meeting.
Facial rejuvenation and body shaping make up the two main categories of today’s medical aesthetic market. In the case of body contouring, the risk of postoperative morbidity, recovery and downtime, has led to a decrease in the amount of surgical liposuction procedures being performed, and an increase in the demand for non-invasive solutions.
Delivering pulsed, focused ultrasound to cause fat cell destruction for long-lasting visible circumference reduction, non-thermal UltraShape Power from Syneron-Candela (Irvine, California, U.S.) is the only device of its kind that can be adjusted to treat all over the body, without pain or downtime. Together with the complementary non-invasive shaping and tightening of VelaShape III, physicians have a powerful armamentarium to achieve exceptional non-invasive body shaping results.
Kybella generated a lot of buzz when it was approved in 2015 as an injectable treatment for double chins. What do physicians have to say about it three years later?
A plastic surgery taskforce recently released recommendations for gluteal fat grafting, a procedure that has a significantly higher mortality rate than any other in the aesthetic space.
What will shape cosmetic medicine in 2018? We asked industry leaders to weigh in with what they think will drive aesthetic medicine’s evolution this year.
While non-surgical fat reduction technologies can yield dramatic results, stubborn and residual swelling often remains present in the treated areas. This is where the Z Wave from Zimmer MedizinSystems (Irvine, Calif.) comes in. Using radial pulse energy, the Z Wave device enhances the outcome of cryolipolysis treatments by transmitting high-energy acoustic waves through soft tissue, which spread radially beneath the skin’s surface.
The non-invasive body contouring device SculpSure has added submental to its FDA clearance areas, including abdomen, love handles, back and thighs.
Still wondering if you should add Cellfina to your practice? One plastic surgeon details his first year of experience.
After failing phase III trial in 2016, this injectable fat dissolver is back in a proof of concept study for treating the double chin.